Skip to content
Screener

Delcath Systems DCTH Operating Cash Flow

Operating Cash Flow at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$40.68M+0.3%
Boston Scientific logo
Boston ScientificBSX
$348M-35.7%
Altimmune logo
AltimmuneALT
-$20.94M-24.4%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
-$6.48M-44.0%
Wave Life Sciences logo
Wave Life SciencesWVE
-$53.58M-16.5%
CTO
Citius Oncology, Inc.CTOR
-$3.83M-179%

Other financials

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$524.3M+57.3%
Enterprise value$479.26M+59.6%
P/E102.3×
P/S5.5×+0.7×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio9.8×-1.0×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Delcath Systems’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 9:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053956
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Inventories(1,461)(3,590)
Accounts payable and accrued expenses2,2354,137
Other liabilities, non-current(441)(235)
Net cash provided by operating activities6,5699,496
Cash flows from investing activities:
Purchase of investments(48,102)(51,152)
Maturities of investments48,10026,127
Purchase of property, plant and equipment(1,073)(538)

Item 1. Financial Statements

FAQ

What is Delcath Systems's operating cash flow?
Delcath Systems (DCTH) reported operating cash flow of $5.71M in Q2 2026.
How has Delcath Systems's operating cash flow changed year-over-year?
Delcath Systems's operating cash flow decreased by 21.7% year-over-year, from $7.29M to $5.71M.
What is the long-term trend for Delcath Systems's operating cash flow?
Over 4 years (2021 to 2025), Delcath Systems's operating cash flow has grown at a -0.1% compound annual growth rate (CAGR), from -$22.6M to $22.52M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Delcath Systems's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude